These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36892169)

  • 21. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's esophagus and Barrett's carcinoma.
    von Rahden BH; Stein HJ; Siewert JR
    Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus.
    Shalauta MD; Saad R
    Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for Barrett's esophagus.
    DeVault KR
    Am Fam Physician; 2004 May; 69(9):2061-3. PubMed ID: 15152952
    [No Abstract]   [Full Text] [Related]  

  • 28. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
    Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflux disease and Barrett's esophagus.
    Qumseya BJ; Wolfsen CL; Wolfsen HC
    Endoscopy; 2011 Nov; 43(11):962-5. PubMed ID: 22057759
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
    Spechler SJ
    Med Clin North Am; 2002 Nov; 86(6):1423-45, vii. PubMed ID: 12510459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett's Esophagus - State of the Art.
    Tanţău M; Laszlo M; Tanţău A
    Chirurgia (Bucur); 2018; 113(1):46-60. PubMed ID: 29509531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's esophagus: clinical characteristics.
    Reynolds JC; Rahimi P; Hirschl D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):441-60. PubMed ID: 12134612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy.
    Shakhatreh MH; Duan Z; Avila N; Naik AD; Kramer JR; Hinojosa-Lindsey M; Chen J; El-Serag HB
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):280-6. PubMed ID: 25004461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance.
    Saxena N; Inadomi JM
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):397-421. PubMed ID: 28577764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.